EGFR and colorectal cancer: These lines of evidence, together with our results, support a notion that miR-193a-3p acts as a negative regulator for the EGFR/ERBB-related pathways in various cancers, although the full mechanisms underlying the miR-193a-3p-EGFR/ERBB regulatory network in colorectal cancer require further elucidation.